ICON

Gold Sponsor

ICON is a global provider of outsourced drug development services to biopharma, medical device, government, biosimilar and generic organisations.

We offer a full range of clinical, consulting and commercial services that range from trial design to full study execution, and from clinical to post-market commercialisation.

Our services are supported by in-depth therapeutic and regulatory expertise and market-leading technology and analytics.

With headquarters in Dublin, Ireland, ICON currently, operates from 97 locations in 38 countries and has approximately 13,100 employees

Visit http://www.iconplc.com/therapeutics/vaccines/